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Abstract 
The reaction between sulfites and nitric oxide or proposed carriers of nitric oxide (nitrosylated bovine serum albumin and 
S-nitrosoglutathione) was investigated as a potential source of the adverse ffects of sulfites on biological systems. Rapid reaction 
occurred between sulfites and all of these reagents. Also, the ability of nitric oxide and these carriers of nitric oxide to inhibit platelet 
aggregation was reversed by low concentrations of sulfites. Counteraction of nitric oxide's ability to function in cell signaling processes 
may be a major cause of sulfite toxicity. 
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Sulfites (widely defined as the sulfiting agents, sulfur 
dioxide gas, metabisulfite, bisulfite and sulfite) are often 
encountered in the environment. Exposure to sulfites may 
result from inhaling sultiar dioxide which may be con- 
verted to the other sulfites upon contact with fluids in the 
air passages [ 1,2] or as the result of the ingestion of foods 
and drugs treated with some type of sulfiting agent [1,3-5]. 
Airborne concentrations of sulfur dioxide as high as 0.23 
ppm have recently been reported and have correlated with 
transient increases in respiratory and heart disease [6,7]. 
Sulfiting agents are used as preservatives in foods, alco- 
holic beverages and drulgs at concentrations as high as 
4000 ppm [1] and studie:~ have shown that metabisulfite, 
bisulfite and sulfur dioxicle all can cause bronchoconstric- 
tion [3-5]. Persons with Jlo history of asthma can experi- 
ence respiratory distress in the presence of high concentra- 
tions of sulfites while asl~hmatics are particularly sensitive 
to sulfites [3-6,8]. 
The mechanism of action of sulfites in precipitating 
asthmatic episodes has not been elucidated. However, 
treatment with drugs suc.h as atropine can alleviate the 
effects of sulfites [5,8]. Since these drugs act on the 
parasympathetic pathway, it was suggested that sulfites 
may affect some mediator within this pathway [3,5,8]. 
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Nitric oxide (NO) functions as a neurotransmitter, it 
inhibits platelet aggregation and it regulates mooth mus- 
cle tone, thereby mediating blood pressure [9-13]. It has a 
short half-life in biological fluids, so carriers of nitric 
oxide such as S-nitrosoglutathione and S-nitrosylated 
serum albumins have been suggested [16,17,21-23]. It has 
previously been shown that the stimulation of muscarinic 
receptors can initiate the production of nitric oxide [13-18], 
followed by the upregulation of its target enzyme, guany- 
late cyclase [10,19,20]. Thus nitric oxide can be considered 
to be a messenger within the parasympathetic pathway. 
The results of this study suggest hat the reaction of nitric 
oxide and its carriers with sulfites may be a major source 
of sulfites' biological toxicity. 
In the absence of oxygen, the partial pressure of nitric 
oxide in solution can be measured irectly using a Clark- 
type oxygen probe [26]. In Fig. 1, aliquots of sulfites 
solution (1 /zL, 0.5 M sulfites) were added to a nitric 
oxide solution at the times indicated by the arrows. The 
rate of change appeared similar to the time of mixing and 
the response time of the instrument. Addition of the same 
quantity of aerated water (1 /zL) produced a barely de- 
tectable signal change. In order to test whether the probe 
was functioning properly, sulfites were added to bring the 
probe reading to zero, followed by addition of known 
amounts of either nitric oxide solution or oxygenated 
buffer. These additions produced the expected response. 
Fig. 1 clearly demonstrated a rapid reaction of nitric oxide 
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Fig. 1. The reaction of nitric oxide with sulfites. Nitric oxide solution was 
made by bubbling nitric oxide gas (98.5%, Aldrich Chem. Co.) for 15 
min into phosphate buffer (50 mM phosphate, 0.1 M NaCI (pH 7.0)) that 
had been purged of oxygen with N 2 gas for 1 h. The nitric oxide partial 
pressure of this solution (10 mL) was monitored with a Biological 
Oxygen Monitor and probe (Yellow Springs Instrument Co.) and is 
shown on the vertical xis. Nitric oxide gives 1/3 the response ofoxygen 
in this system (manufacturer's stimate). A solution of sulfites (1 /xL of 
0.5 M sulfites made from sodium etabisulfite) was added at each arrow 
using a gas tight syringe fitted with a 22-gauge Teflon tube. Exposure to 
air was minimized and the solution was stirred continuously at room 
temperature. The vertical bar at the lower left indicates the response of
the moniter to 53 ~M oxygen, determined bya standard procedure [32]. 
with sulfites. The dinitrososulfite ion, a 2:1 divalent anion 
complex of nitric oxide and sulfite, is known to form when 
nitric oxide gas is passed through basic solutions of sul- 
rites [24]. Though not rigorously determined, the stoi- 
chiometry of the reaction between itric oxide and sulfites 
as determined from data such as that in Fig. 1, ranged from 
1.34:1 to 2:1 for various additions and experiments. 
Nitric oxide has a short half-life in extracellular media 
and may not function as a paracrine-type messenger itself, 
but in the form of a complex with carrier molecules 
[16,17,23]. Fig. 2 shows the results of reaction of sulfites 
with S-nitrosylated bovine serum albumin, one of the 
proposed carriers of nitric oxide [21,23]. The S-nitrosyl 
derivative can be measured spectrophotometrically t 335 
nm [21-23]. Sulfites clearly reacted with the nitrosylated 
thiols and bleached the chromophore (Fig. 2). 
The rate and extent of bleaching of the chromophore at 
335 nm was dependent on the amount of sulfites added but 
not in direct ratio. That is, doubling of sulfites did not 
produce twice as much bleaching. This suggested the 
possibility of a heterogeneous population of nitrosylated 
groups, some of which were readily susceptible to sulfites 
while others were not. Sulfites can also react with disulfide 
bonds to produce free sulfhydryls that may undergo S- 
nitrosothiol-thiol exchange [22,27]. Bovine serum albumin 
has 17 disulfide bonds and one free sulfhydryl group 
[28,29], so that a heterogeneous population is possible. 
While the question of heterogeneity was not addressed 
further, subsequent results showed that bleaching of ab- 
sorbance at 335 nm was correlated with the loss of impact 
of nitrosylated bovine serum albumin on platelets. Studies, 
similar to those in Fig. 2, demonstrated reaction of sulfites 
with S-nitrosoglutathione, another proposed carrier of ni- 
tric oxide (not shown). 
Since sulfites indeed react with nitric oxide and with 
carriers of nitric oxide, then the presence of sulfites should 
reverse the ability of nitric oxide to function in biological 
processes. An example of a nitric oxide effect is the 
inhibition of platelet aggregation [10,23,25]. In Fig. 3, a 
solution of nitric oxide effectively inhibited the onset of all 
stages of aggregation. Sulfites added prior to nitric oxide 
lessened its effect on platelet aggregation i  a concentra- 
tion-dependent manner. The sequence of addition (nitric 
oxide, thrombin or sulfites; data not shown) had only 
minor effects on this pattern of behavior. In Fig. 4, platelet 
aggregation was inhibited by S-nitrosoglutathione. Again, 
sulfites reversed this effect. Prior incubation of S-nitro- 
soglutathione with sulfites for 15 min nearly abolished the 
efficacy of S-nitrosoglutathione (tracing 4, Fig. 4). Results 
similar to those presented in Fig. 4 were also obtained 
when the S-nitrosylated bovine serum albumin was used in 
place of S-nitrosoglutathione (result not shown). The con- 
centrations of sulfites used in these experiments had no 
detectable effect on platelet aggregation (Fig. 4, tracing 5). 
At high concentrations (> 1.5 mM), sulfites became in- 
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Fig. 2. Reaction of S-nitrosylated bovine serum albumin with sulfites. 
S-nitrosyl bovine serum albumin was produced following a published 
procedure [23]. The bovine serum albumin (10 mg/mL in l0 mM 
Hepes/0. l M NaC1 (pH 7.4), approx. 20 mL) was dialyzed for 1 h 
against Hepes buffer (100 mL) that was constantly purged with N 2 gas. 
Nitric oxide gas was then passed through the dialysis buffer for 15 min. 
Finally, the protein solution was dialyzed against 2 L Hepes buffer for 18 
h. The absorption spectrum of the derivatized serum albumin showed a
peak at 335 nm (A = 0.066), characteristic of S-nitrosylated bovine 
serum albumin. The protein concentration and the published extinction 
coefficient a  335 nm [22] gave a stoichiometry of 0.5 mol of S-nitrosy- 
lated derivative per mol of serum albumin. The change in absorbance at 
335 nm after addition of sulfites olution was followed at room tempera- 
ture using a Beckman DU 70 spectrophotometer. The uppermost tracing 
represents the absorbance with no sulfites added, the second and third 
tracings how the result after addition of 200 and 500 ~M sulfites, 
respectively. 
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Fig. 3. Effects of sulfites on nitric: oxide inhibition of platelet aggregation. 
Platelet concentrate (Memorial Blood Center of Minneapolis) was used 
on the 6th or 7th day after being drawn. The platelets were constantly 
agitated uring storage and were washed by standard procedures [31] just 
before use. Various preparations used in this study contained 500000+ 
100000 platelets per /xL and were used undiluted. Platelet aggregation 
was monitored using a Chrono-l,og 330 platelet aggregometer at 37 ° C. 
Platelet aggregation was initiat,;d by addition of 40 mU of bovine 
thrombin (2000 U/mg,  prepared as in [30]) at the arrow. Sulfites and/or 
nitric oxide were added less them 1 min prior to thrombin. Tracing 1 
shows the results when 4 /~M nitric oxide was added prior to thrombin. 
Tracing 4 shows the control experiment without nitric oxide. Tracings 2 
and 3 show the results for reactions that contained nitric oxide (4 /xM) 
plus 30 u~M or 100 ~M sulfites (sodium metabisulfite), respectively. The 
tracings have been offset for clarity. 
hibitors of platelet aggregation (not shown), so that their 
opposite impact at low concentration and in the presence 
of nitric oxide (Figs. 3 and 4) appeared to stem from 
reaction with nitric oxide or its derivatives. 
Very low concentrations of nitric oxide carriers are 
highly effective at mediating nitric oxide's physiological 
effects [21,23] and 600 nld S-nitrosoglutathione (Fig. 4) 
represented an excess that inhibited platelet aggregation 
completely. That microm~lar concentrations of sulfites 
partially reversed the effects of excess reagent suggested 
that much lower concentrations of sulfites would influence 
the affects of a minimum dose of nitric oxide reagent. 
Furthermore, it is possible that other nitric oxide response 
systems are even more sensitive to sulfites. Thus, the nitric 
oxide signaling pathway raay be exquisitely sensitive to 
sulfites. 
Both sulfites and nitric oxide are highly reactive inor- 
ganic materials so that rapid mutual interaction is not 
surprising. Although not established in this study, it is 
possible that the direct reaction of nitric oxide and sulfites 
proceeds to a known complex [24]. This study found that 
sulfites also react with S-nitroso compounds. Again, while 
reaction mechanisms and products can readily be postu- 
lated, further work will be needed to establish the exact 
chemistry and products formed from these reactions in 
dilute buffered solutions. 
Nitric oxide is used not only as a messenger, it is also 
used as a bactericide, and excessive production of nitric 
oxide is toxic. Septic shock, a situation were the smooth 
muscle surrounding blood vessels relax excessively, is a 
potential result of an overproduction f nitric oxide [10]. If 
sulfites indeed react with nitric oxide in biological sys- 
tems, they might function to reverse such effects. 
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Fig. 4. Effects of sulfites on S-nitrosoglutathione i hibition of platelet 
aggregation. Platelets were prepared as outlined in Fig. 3. Platelet aggre- 
gation was initiated in each case by the addition of 20 mU thrombin at 
the arrow. S-nitrosoglutathione (600 nM, from Molecular Probes), added 
before thrombin, gave the results hown in the tracing 1. Tracing 6 shows 
the comparable xperiment but without S-nitrosoglutathione. Tracings 2 
and 3 show the results when S-nitrosoglutathione (600 nM) plus 50 or 
100/.tM sulfites, respectively, were added before the thrombin. Tracing 4 
shows the result of the addition of S-nitrosoglutathione (600 nM) that had 
been pre-incubated for 15 min in a solution that contained 200 jzM 
sulfites and 100/xM S-nitrosoglutathione. In this experiment, the concen- 
tration of sulfites in the final platelet solution was 1.2 /zM, inadequate o
have a detectable effect on 600 nM S-nitrosoglutathione if it were added 
directly to the platelet solution. Tracing 5 shows the result when 100 /xM 
bisulfite and thrombin were the only additives. The tracings have been 
offset for clarity. 
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Overall, this study has shown that sulfites are capable 
of reacting not only with nitric oxide but also with several 
of its derivatives. This reaction affected nitric oxide's 
ability to function as a physiological messenger. While the 
speed of reaction and sensitivity of nitric oxide to sulfites 
make it seem likely that this is a major source of sulfite 
toxicity, further studies will be needed to determine the 
quantitative contributions of this mechanism to the adverse 
reactions caused by sulfiting agents. 
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